Mineralys Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
MLYS Nasdaq 2830 mineralystx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Mineralys Therapeutics, Inc.

Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026 - Oct 22nd, 2026 4:40 pm
Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats - Oct 19th, 2026 2:05 pm
Mineralys Therapeutics (MLYS) Shares New Lorundrostat Data, Is The Stock A Bargain? - Oct 12th, 2026 5:26 pm
Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026 - Oct 9th, 2026 7:00 am
Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026 - Oct 1st, 2026 2:05 pm
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Sep 29th, 2026 2:05 pm
Mineralys Therapeutics (MLYS) Faces A Fresh Valuation Test On New Lorundrostat Data - Sep 28th, 2026 11:08 am
Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum - Sep 24th, 2026 2:05 pm
Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026 - Sep 23rd, 2026 2:05 pm
Mineralys Therapeutics to Participate in the Wells Fargo 21st Annual Healthcare Conference - Aug 26th, 2026 6:00 am
Mineralys (MLYS) Q2 2026 Earnings Call Transcript - Aug 18th, 2026 5:13 pm
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - Aug 13th, 2026 2:05 pm
Mineralys Therapeutics Inc (MLYS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and ... - Aug 11th, 2026 11:01 pm
Mineralys Therapeutics, Inc. Q2 2026 Earnings Call Summary - Aug 11th, 2026 8:49 pm
Mineralys Therapeutics Q2 Earnings Call Highlights - Aug 11th, 2026 5:04 pm
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 11th, 2026 2:05 pm